![Michael Tardugno](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Tardugno
Président chez
IMUNON, INC.
Fortune : 150 459 $ au 31/05/2026
Profil
Mr. Michael H.
Tardugno is an Executive Chairman at Imunon, Inc. Mr. Tardugno was previously employed as a Senior Vice President & General Manager by Mylan Technologies, Inc., an Executive Vice President by Songbird Holdings LLC, a Senior Vice President-Technical Operations by Bristol Myers Squibb Co., a Senior Vice President-Technical Operations by Convatec, Inc., a Plant Manager-Ross Laboratories Division by Abbott Laboratories, and a VP-Technology Development & Manufacturing by Bausch & Lomb, Inc. He also served on the board at THO Inc.,.
He received his undergraduate degree from St. Bonaventure University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMUNON, INC. 2,74 % | 02/07/2026 | 69 018 ( 2,74 % ) | 150 459 $ | 31/05/2026 |
Postes actifs de Michael Tardugno
| Sociétés | Poste | Début |
|---|---|---|
| IMUNON, INC. | Président | 07/10/2014 |
Anciens postes connus de Michael Tardugno
| Sociétés | Poste | Fin |
|---|---|---|
Mylan Technologies, Inc.
 Mylan Technologies, Inc. Containers/PackagingProcess Industries Manufactures and distributes transdermal products | Directeur des opérations | 01/12/2006 |
Songbird Holdings LLC
 Songbird Holdings LLC Medical SpecialtiesHealth Technology Designs and manufactures hearing devices | Corporate Officer/Principal | 01/01/2005 |
ConvaTec, Inc.
 ConvaTec, Inc. Medical SpecialtiesHealth Technology Develops and manufactures products for the ostomy management, advanced chronic and acute wound care and continence care services | Directeur Technique/Scientifique/R&D | 01/01/1998 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/1998 |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Corporate Officer/Principal | 01/01/1995 |
Formation de Michael Tardugno
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Mylan Technologies, Inc.
Mylan Technologies, Inc. Containers/PackagingProcess Industries Manufactures and distributes transdermal products | Process Industries |
THO Inc.,
 THO Inc., BiotechnologyHealth Technology Develops proteomic technologies | Health Technology |
ConvaTec, Inc.
ConvaTec, Inc. Medical SpecialtiesHealth Technology Develops and manufactures products for the ostomy management, advanced chronic and acute wound care and continence care services | Health Technology |
St. Bonaventure University
 St. Bonaventure University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Songbird Holdings LLC
Songbird Holdings LLC Medical SpecialtiesHealth Technology Designs and manufactures hearing devices | Health Technology |
Choisissez Zonebourse 
